1. Home
  2. FSK vs ADMA Comparison

FSK vs ADMA Comparison

Compare FSK & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSK
  • ADMA
  • Stock Information
  • Founded
  • FSK 2007
  • ADMA 2004
  • Country
  • FSK United States
  • ADMA United States
  • Employees
  • FSK N/A
  • ADMA N/A
  • Industry
  • FSK Investment Managers
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FSK Finance
  • ADMA Health Care
  • Exchange
  • FSK Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • FSK 5.4B
  • ADMA 5.1B
  • IPO Year
  • FSK N/A
  • ADMA N/A
  • Fundamental
  • Price
  • FSK $15.87
  • ADMA $15.90
  • Analyst Decision
  • FSK Hold
  • ADMA Strong Buy
  • Analyst Count
  • FSK 7
  • ADMA 3
  • Target Price
  • FSK $19.14
  • ADMA $27.67
  • AVG Volume (30 Days)
  • FSK 1.8M
  • ADMA 3.0M
  • Earning Date
  • FSK 11-05-2025
  • ADMA 11-06-2025
  • Dividend Yield
  • FSK 17.47%
  • ADMA N/A
  • EPS Growth
  • FSK N/A
  • ADMA 469.09
  • EPS
  • FSK 0.78
  • ADMA 0.85
  • Revenue
  • FSK $1,646,000,000.00
  • ADMA $474,174,000.00
  • Revenue This Year
  • FSK N/A
  • ADMA $21.08
  • Revenue Next Year
  • FSK N/A
  • ADMA $25.98
  • P/E Ratio
  • FSK $20.59
  • ADMA $18.37
  • Revenue Growth
  • FSK N/A
  • ADMA 43.58
  • 52 Week Low
  • FSK $16.01
  • ADMA $13.50
  • 52 Week High
  • FSK $24.10
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • FSK 16.63
  • ADMA 40.74
  • Support Level
  • FSK $17.90
  • ADMA $15.14
  • Resistance Level
  • FSK $18.21
  • ADMA $15.96
  • Average True Range (ATR)
  • FSK 0.29
  • ADMA 0.55
  • MACD
  • FSK -0.12
  • ADMA -0.07
  • Stochastic Oscillator
  • FSK 0.75
  • ADMA 33.48

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: